Additionally, the FMT was associated with a reduced number of hospitalizations due to liver-related complications, and there was a significant improvement in cognitive outcomes between baseline and post-treatment in the FMT group but none among those undergoing standard of care (SOC)
Both agents have proven cardiovascular benefit, but semaglutide's evidence extends to the overweight/obese non-diabetic population, a substantially broader indication
Common contributing factors include poor posture, sedentary lifestyle, improper lifting technique, excess body weight, and genetic predisposition
Most patients experience no discomfort
Heartburn specifically affected roughly 15% of patients, indicating it is a frequent side effect whose severity often rises with higher doses or overlapping risk factors
The insulin regimen in type 2 diabetes should be tailored to the individual to reach their individualized glycemic levels and to minimize risk of hypoglycemia